Human glioblastoma cells release interleukin 6 in vivo and in vitro.
about
Characterization of the Aalpha and Abeta subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolutionCell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells.Exciting new advances in neuro-oncology: the avenue to a cure for malignant gliomaModulation in vitro of human natural cytotoxicity, lymphocyte proliferative response to mitogens and cytokine production by essential fatty acidsInflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression.Accessing key steps of human tumor progression in vivo by using an avian embryo model.The deadly connection between endoplasmic reticulum, Ca2+, protein synthesis, and the endoplasmic reticulum stress response in malignant glioma cells.The TRPC channel blocker SKF 96365 inhibits glioblastoma cell growth by enhancing reverse mode of the Na(+) /Ca(2+) exchanger and increasing intracellular Ca(2+).Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.Microglia in close vicinity of glioma cells: correlation between phenotype and metabolic alterationsLoss of tumoral expression of soluble IL-6 receptor is associated with disease progression in colorectal cancerLAP2 is widely overexpressed in diverse digestive tract cancers and regulates motility of cancer cells.Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization.Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouseN-methylpurine DNA glycosylase and DNA polymerase beta modulate BER inhibitor potentiation of glioma cells to temozolomideTargeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma.Association between Serum Levels of Interleukin-6 and Stage of Laryngeal CancerGlioblastoma cancer stem-like cells: implications for pathogenesis and treatment.Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomasExpression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigmCellular and functional characterization of immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated synthesis of biologically active TGF-beta.Preoperative thrombocytosis predicts poor survival in patients with glioblastoma.Studying a complex tumor: potential and pitfalls.The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma.Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer.Serum levels of interleukin 6 in patients with lung cancer.A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agentInterleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells.Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis.Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate.Activation of the NF-κB pathway by the STAT3 inhibitor JSI-124 in human glioblastoma cells.mRNA coding for neurotransmitter receptors in a human astrocytoma.Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomasA novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathwayDistribution of endogenous tumour necrosis factor alpha in gliomas.Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14.
P2860
Q24535025-C66E0C02-5357-42E8-B96C-86B81AF2E487Q24538924-303AC5E5-4027-4B8C-A99A-F347961E6E36Q24632791-D4A66456-AC26-4EEF-86D3-72D964A91330Q28379281-832FF502-8075-44D9-9BAB-72A9C4CBB832Q30414501-AADA92F2-64D3-4525-98EA-807C671E11E5Q33818411-C8A3569B-08B8-419C-A043-F6A146582813Q33894478-83F8591D-4BD6-4B8C-9B12-4AC9D1EEE7FFQ33929772-92EA335C-2BA2-4AB7-90E9-00CF4EA8FB13Q34069375-F621AE22-F6E7-4392-87DA-10257DE400B3Q34245550-3362B764-0375-4DDA-926B-21AF07ADC70DQ34253678-5F99918C-36E5-4557-A73D-D3F5B0662CABQ34321439-96331CB5-10E3-4D95-AB16-1B92AB1D3F28Q34565145-58A7C7C3-9301-4CE7-ABBA-82D935021F4FQ34917061-8A54D5FC-CC41-4090-BA6E-DB425CEE6E2CQ34977358-A4577E8D-0CF9-4757-BC7F-B26F639F297AQ35143738-D7B6F6D7-2EF9-4D18-A17E-31A678D2F33DQ35708994-45B4338A-4D21-4D78-BCED-3FEE16D26E68Q35719080-E261AA8D-A962-4A2F-B7B6-81218DBD67DCQ35796211-CEB4895F-8E88-4869-BFDA-F7B7FB7AF85AQ35804856-DCEFF356-DE7E-40E3-91B2-D083F9592D14Q35847139-62C52D2A-EAA8-4390-8F30-29436DEABA95Q35870489-9AE59096-C3DB-4440-869B-0B75A3A9D539Q35929525-9BB0E5BD-0B4F-448C-BF4A-31AC7C2640BAQ35967008-47D63E4A-40A1-4106-9A6A-DE452F16B1F9Q36080397-0A9018F3-7C5D-4234-9838-6120A2E71E34Q36080837-19717B85-31CF-43BF-99C5-2A7A285CC3C5Q36090064-22BF3E9F-B066-47CA-A6E1-BC6B63604DB7Q36233022-77DAFD8B-9F60-45CC-A53C-AE76CC854F47Q36368481-8BE821CB-CE03-469C-BBF7-2C14113A2190Q36380713-12E0FC7C-D8CA-42EE-807F-42AEEB9472C2Q36620446-3A253064-5CFB-440F-9A9F-C10DC9D6F51FQ36852167-05A1590E-77CC-44F3-81C7-A6460E3690AAQ36952481-53737D30-1DDD-4BFA-85F7-478664F6253EQ37174303-84078549-CE41-4483-9AB5-57725EC26159Q37189154-19836D16-1D2A-40D5-9F4E-ED79326218A7Q37209620-29C1BC84-B79A-4DE5-A650-612A7B0A6724Q37228242-0C3AC622-B131-44E5-A25A-3587A6206FBAQ37364901-302D3961-BB5C-4C3E-8257-B4D8748BD822Q37599151-15DC661B-3BD9-4B82-8B72-AC19FA4BA881Q37641789-CD214087-6E64-462C-A032-8ACF93B5ABFB
P2860
Human glioblastoma cells release interleukin 6 in vivo and in vitro.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Human glioblastoma cells release interleukin 6 in vivo and in vitro.
@en
type
label
Human glioblastoma cells release interleukin 6 in vivo and in vitro.
@en
prefLabel
Human glioblastoma cells release interleukin 6 in vivo and in vitro.
@en
P2093
P1433
P1476
Human glioblastoma cells release interleukin 6 in vivo and in vitro.
@en
P2093
A C Diserens
N de Tribolet
Y Sawamura
P304
P407
P577
1990-10-01T00:00:00Z